Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Aging-related disorders pose significant challenges due to their complex interplay of physiological and metabolic factors, including inflammation, oxidative stress, and mitochondrial dysfunction. Curcumin, a natural compound with potent antioxidant and anti-inflammatory properties, has emerged as a promising candidate for mitigating these age-related processes. However, gaps in understanding the precise mechanisms of curcumin’s effects and the optimal dosages for different conditions necessitate further investigation. This systematic review synthesizes current evidence on curcumin’s potential in addressing age-related disorders, emphasizing its impact on cognitive function, neurodegeneration, and muscle health in older adults. By evaluating the safety, efficacy, and mechanisms of action of curcumin supplementation, this review aims to provide insights into its therapeutic potential for promoting healthy aging. A systematic search across three databases using specific keywords yielded 2256 documents, leading to the selection of 15 clinical trials for synthesis. Here, we highlight the promising potential of curcumin as a multifaceted therapeutic agent in combating age-related disorders. The findings of this review suggest that curcumin could offer a natural and effective approach to enhancing the quality of life of aging individuals. Further research and well-designed clinical trials are essential to validate these findings and optimize the use of curcumin in personalized medicine approaches for age-related conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ikram, M., Saeed, K., Khan, A., Muhammad, T., Khan, M., Jo, M., Rehman, S., & Kim, M. (2019) · Nutrients · doi:10.3390/nu11051082 · Cited by 97 · cited 1×
“Ikram et al. investigated the neuroprotective mechanisms of dietary supplementation of 50 mg/kg of curcumin for 6 weeks on male C57BL/6N mice and HT22 cells from the hippocampus of mice with neurodegeneration [159].”
BackgroundRetractedThe PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Malhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099 · cited 1×
“According to forecasts from the World Health Organization, it is estimated that it will become the main global burden of disease in the world by 2030 [258,259].”
MethodNeuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345
Prevalence of frailty in community-dwelling older persons: a systematic review
Collard, R. M., Boter, H., Schoevers, R. A., & Oude Voshaar, R. C. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04054.x · Cited by 3,073
Studenski, S. A., Peters, K. W., Alley, D. E., Cawthon, P. M., McLean, R. R., Harris, T. B., Ferrucci, L., Guralnik, J. M., Fragala, M. S., Kenny, A. M., et al. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu010 · Cited by 2,545
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336 · cited 1×
“Yang et al. showed that in oral ingestion or peripheral injection of curcumin in Swedish Mutant (APPsw) Tg2576 transgenic mice, there was a blood–brain barrier crossing of curcumin that binds to amyloid plaques in vivo and in vitro [178].”
BackgroundFrailty as a predictor of surgical outcomes in older patients
Makary, M. A., Segev, D. L., Pronovost, P. J., Syin, D., Bandeen-Roche, K., Patel, P., Takenaga, R., Devgan, L., Holzmueller, C. G., Tian, J., et al. (2010) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2010.01.028 · Cited by 2,184
Alexopoulos, G. S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66665-2 · Cited by 2,024 · cited 1×
“The processes associated with aging and diseases, such as arteriosclerosis and inflammatory, immunological, and endocrine changes, impair the integrity of the frontostriatal pathways, the hippocampus, and the amygdala, increasing susceptibility to depression [265,266].”
BackgroundLim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530
Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro
Ono, K., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20025 · Cited by 1,254 · cited 1×
“Fortunately, in addition to AChE inhibitor medications, studies have shown that curcumin therapy acts protectively in the pathogenesis of AD, reducing OS and inflammation, in addition to inhibiting the formation of A β fibrils from A β 40 (1–40) and A β 42(1–42) and amyloid plaques [170–175].”
BackgroundFerrari, A. J., Somerville, A. J., Baxter, A. J., Norman, R., Patten, S. B., Vos, T., & Whiteford, H. A. (2013) · Psychological Medicine · doi:10.1017/s0033291712001511 · Cited by 1,230 · cited 1×
“Signi fi cant personal su ff ering and economic loss result from the increased risk of suicide and worldwide morbidity resulting from depression [260,261,262,263,264].”
BackgroundPhenotype of frailty: characterization in the women's health and aging studies
Bandeen-Roche, K., Xue, Q.-L., Ferrucci, L., Walston, J., Guralnik, J. M., Chaves, P., Zeger, S. L., & Fried, L. P. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.3.262 · Cited by 1,215
Haapakoski, R., Mathieu, J., Ebmeier, K. P., Alenius, H., & Kivimäki, M. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.06.001 · Cited by 1,129
Inflammatory markers and loss of muscle mass (sarcopenia) and strength
Schaap, L. A., Pluijm, S. M. F., Deeg, D. J. H., & Visser, M. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.049 · Cited by 1,047
Prevalence of Frailty in Middle-Aged and Older Community-Dwelling Europeans Living in 10 Countries
Santos-Eggimann, B., Cuenoud, P., Spagnoli, J., & Junod, J. (2009) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glp012 · Cited by 963
Liu, Y., Ho, R. C.-M., & Mak, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.003 · Cited by 948
Frailty in older adults: a nationally representative profile in the United States
Bandeen-Roche, K., Seplaki, C. L., Huang, J., Buta, B., Kalyani, R. R., Varadhan, R., Xue, Q.-L., Walston, J. D., & Kasper, J. D. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv133 · Cited by 800
The Role of Inflammation in Age-Related Sarcopenia
Dalle, S., Rossmeislova, L., & Koppo, K. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.01045 · Cited by 668
Major Depression and Its Recurrences: Life Course Matters
Monroe, S. M., & Harkness, K. L. (2022) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-072220-021440 · Cited by 608
Burden of Disease—Implications for Future Research
Michaud, C. M. (2001) · JAMA · doi:10.1001/jama.285.5.535 · Cited by 594 · cited 1×
“According to forecasts from the World Health Organization, it is estimated that it will become the main global burden of disease in the world by 2030 [258,259].”
MethodNg, A., Tam, W. W., Zhang, M. W., Ho, C. S., Husain, S. F., McIntyre, R. S., & Ho, R. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-30487-6 · Cited by 572
Tiwari, S. K., Agarwal, S., Seth, B., Yadav, A., Nair, S., Bhatnagar, P., Karmakar, M., Kumari, M., Chauhan, L. K. S., Patel, D. K., et al. (2014) · ACS Nano · doi:10.1021/nn405077y · Cited by 558 · cited 1×
“Fortunately, in addition to AChE inhibitor medications, studies have shown that curcumin therapy acts protectively in the pathogenesis of AD, reducing OS and inflammation, in addition to inhibiting the formation of A β fibrils from A β 40 (1–40) and A β 42(1–42) and amyloid plaques [170–175].”
BackgroundSolleiro-Villavicencio, H., & Rivas-Arancibia, S. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00114 · Cited by 463
The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease
Minter, M. R., Taylor, J. M., & Crack, P. J. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13411 · Cited by 451
The Role of Curcumin in Aging and Senescence: Molecular Mechanisms
Zia, A., Farkhondeh, T., Pourbagher-Shahri, A. M., & Samarghandian, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111119 · Cited by 378
Cox, K. H., Pipingas, A., & Scholey, A. B. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114552744 · Cited by 368
The Role of Oxidative Stress in Depressive Disorders
Maria Michel, T., Pulschen, D., & Thome, J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803523554 · Cited by 268 · cited 1×
“…and inhibits the expression of monoamine oxidase enzymes [17–21]; regulates hypothalamic–pituitary–adrenal (HPA) disorders [274–276]; reduces NO [277–282]; repairs neurodegeneration and increases neurogenesis and neuronal plasticity, which normally increases BDNF levels [283–287]; regulates…”
BackgroundRole of Age-Related Mitochondrial Dysfunction in Sarcopenia
Ferri, E., Marzetti, E., Calvani, R., Picca, A., Cesari, M., & Arosio, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155236 · Cited by 224
Reglodi, D., Renaud, J., Tamas, A., Tizabi, Y., Socías, S. B., Del-Bel, E., & Raisman-Vozari, R. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.10.004 · Cited by 162 · cited 1×
“One study showed that it is possible to reduce deficits related to PD by raising the level of antioxidant enzymes only with curcumin [207].”
BackgroundPhysical Exercise and Myokines: Relationships with Sarcopenia and Cardiovascular Complications
Barbalho, S. M., Flato, U. A. P., Tofano, R. J., Goulart, R. D. A., Guiguer, E. L., Detregiachi, C. R. P., Buchaim, D. V., Araújo, A. C., Buchaim, R. L., Reina, F. T. R., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103607 · Cited by 156 · cited 1×
“Sarcopenia is linked to several comorbidities besides disability, such as osteoporosis, DM2, and obesity [235–237].”
BackgroundSelf-citationLiu, D., Wang, Z., Gao, Z., Xie, K., Zhang, Q., Jiang, H., & Pang, Q. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.05.068 · Cited by 151 · cited 1×
“…neurotransmitter levels, and inhibits the expression of monoamine oxidase enzymes [17–21]; regulates hypothalamic–pituitary–adrenal (HPA) disorders [274–276]; reduces NO [277–282]; repairs neurodegeneration and increases neurogenesis and neuronal plasticity, which normally increases BDNF levels…”
BackgroundValotto Neto, L. J., Reverete de Araujo, M., Moretti Junior, R. C., Mendes Machado, N., Joshi, R. K., dos Santos Buglio, D., Barbalho Lamas, C., Direito, R., Fornari Laurindo, L., Tanaka, M., et al. (2024) · Antioxidants · doi:10.3390/antiox13040393 · Cited by 146 · cited 2×
“Natural bioactive compounds have been used for thousands of years as adjuvants in therapeutic practice due to their efficiency, low cost, few side effects, and easy use [20–22].”
BackgroundSelf-citationThota, R. N., Acharya, S. H., & Garg, M. L. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-0967-x · Cited by 127 · cited 1×
“Thota et al. [296] examined the effects of administering 180 mg/day of curcumin on the insulin resistance of a group of people at high risk of developing DM2, and it was demonstrated that curcumin showed an improvement in insulin resistance index in the lipid profile, fasting insulin, GSK-3 β , and…”
BackgroundMehla, J., Gupta, P., Pahuja, M., Diwan, D., & Diksha, D. (2020) · Brain Sciences · doi:10.3390/brainsci10120964 · Cited by 108
Ruan, Y., Xiong, Y., Fang, W., Yu, Q., Mai, Y., Cao, Z., Wang, K., Lei, M., Xu, J., Liu, Y., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01524-4 · Cited by 85 · cited 1×
“A second nanomaterial with curcumin also reduced/inhibited neuronal death, as NLRP3 promotes the synthesis of a speck-like protein associated with apoptosis containing a CARD (ASC), a protein that recruits and activates pro-caspase-1 and IL-18 contributing to the activation of neuronal death [192].”
BackgroundKobayashi, H., Ohnishi, T., Nakagawa, R., & Yoshizawa, K. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4405 · Cited by 79
Minniti, G., Laurindo, L. F., Machado, N. M., Duarte, L. G., Guiguer, E. L., Araujo, A. C., Dias, J. A., Lamas, C. B., Nunes, Y. C., Bechara, M. D., et al. (2023) · Life · doi:10.3390/life13122270 · Cited by 56 · cited 1×
“…Named “hallmarks of aging”, this process is linked to molecular events such as dysregulated nutrient sensing, telomere wear, genomic instability, epigenetic changes, cellular senescence, loss of proteostasis, altered intercellular communication, and stem cell exhaustion [73,74,75,76,77,78,79,80].”
BackgroundSelf-citationCurcumin and hesperetin attenuate D-galactose-induced brain senescence in vitro and in vivo
Lee, J., Kim, Y. S., Kim, E., Kim, Y., & Kim, Y. (2020) · Nutrition Research and Practice · doi:10.4162/nrp.2020.14.5.438 · Cited by 41 · cited 2×
“Zhi et al. [44] investigated male C57BL/6 mice with trigeminal neuralgia administered 100 mg/kg/day curcumin twice a day for 14 days to observe its effects on orofacial allodynia and cognitive impairment and showed an increase in the density of dendritic spines, and in the regulation and proportion…”
BackgroundMethod
Cited by
Parkinson’s Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation
Tanaka, M. (2025) · doi:10.20944/preprints202506.2099.v2 · Cited by 57
Self-citationTanaka, M. (2025) · doi:10.20944/preprints202412.0679.v2 · Cited by 42
Self-citationQuinoline Quest: Kynurenic Acid Strategies for Next-Generation Therapeutics via Rational Drug Design
Tanaka, M., Szatmári, I., & Vécsei, L. (2025) · doi:10.20944/preprints202503.2399.v1 · Cited by 30
Self-citationTanaka, M., Battaglia, S., & Liloia, D. (2025) · Biomedicines · doi:10.3390/biomedicines13051045 · Cited by 24
“These findings energize ongoing efforts to combat and possibly reverse cognitive decline [93,94].”
Self-citationFrom Microbial Switches to Metabolic Sensors: Rewiring the Gut–Brain Kynurenine Circuit
Tanaka, M., & Vécsei, L. (2025) · doi:10.20944/preprints202506.0880.v1 · Cited by 24
Self-citation
Metadata
- Authors
- Nunes, Y. C., Mendes, N. M., Pereira de Lima, E., Chehadi, A. C., Lamas, C. B., Haber, J. F. S., dos Santos Bueno, M., Araújo, A. C., Catharin, V. C. S., Detregiachi, C. R. P., Laurindo, L. F., Tanaka, M., Barbalho, S. M., & Marin, M. J. S.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2024-08-15
- Volume
- 16
- Issue
- 16
- Pages
- 2721
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W4401643377
- Cited by
- 69
- References
- 39
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.